GSK Aims To Launch 13 Blockbusters In Five Years

Immuno-Oncology Central To Ambitions

 
• By Andrew McConaghie
  
GSK HQ
The consumer health division spin-out in 2022 will leave behind a leaner GSK focused on biopharma and vaccines.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip